Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity.
We have examined MPTP toxicity to dopamine neurons of mice homozygous for a transgenic knockout of the p53 growth control gene (p53-/-). MPTP at a total dose of 96 mg/kg administered in four doses over two days produced a non-homogeneous loss of striatal dopamine transport sites and quantitatively reduced 3H-mazindol binding to similar degrees in p53-/- and wild type controls 2 and 3 weeks after starting MPTP. Nigral DA neurons stained immunohistochemically for tyrosine hydroxylase were counted using both manual and automated methods and found to be reduced 29-34% in wild type controls but were not reduced in p53-/-. Mean DA neuronal surface areas were reduced 63-68% by MPTP in controls and 35-50% in p53-/-. We conclude that p53 protein appears necessary for complete expression of MPTP neurotoxicity to dopamine neurons. Our findings suggest that the p53 gene and other growth control genes may regulate dopamine neuronal death in PD.
Department of Neurology, University of Virginia School of Medicine, Charlottesville 22908, USA.
P A
PA
Trimmer
T S
TS
Smith
A B
AB
Jung
J P
JP
Bennett
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D002452:Cell Count; D003342:Corpus Striatum / Q000201:enzymology; D004298:Dopamine / Q000378:metabolism*; D016158:Genes, p53; D007150:Immunohistochemistry; D008454:Mazindol / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout / Q000235:genetics* / Q000502:physiology; D008822:Mice, Transgenic / Q000502:physiology*; D009474:Neurons / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology*; D009498:Neurotoxins / Q000494:pharmacology*; D013378:Substantia Nigra / Q000201:enzymology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D009498:Neurotoxins; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008454:Mazindol; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine